Aspen Aerogels, Inc. · NYSE:ASPN
Aspen Aerogels — Q3 2022 Earnings Presentation
10 slides from Aspen Aerogels's earnings presentation, Oct 27, 2022
Slide 1: Aspen Aerogels Q3 2022 Financial Results Call
October 27, 2022 ASPEN AEROGELS Q 3 2 0 2 2 F I N A N C I A L R E S U LT S C A L L
Slide 2: Disclaimer on Forward Looking Statements
Disclaimer on Forward Looking Statements This presentation contains statements that constitute “forward‐looking statements” under the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “believe,” “could,” “estimate,” “expect,” “guidance,” “intend,” “may,” “plan,” “potential,”
Slide 3: Disclaimer on Forward Looking Statements
Disclaimer on Forward Looking Statements The presentation contains information regarding certain financial targets with respect to the Company. Such financial targets constitutes forward looking information and is for illustrative purposes only and should not be relied upon as necessarily being indi
Slide 4: Q3 Developments and Recent Highlights
Q3 Developments and Recent Highlights 2022 Revenue Guidance Recap Q3 and Recent Highlights $ in millions 150 190 • 21% YoY Quarterly Revenue Growth February 145 155 • Annual scheduled plant shutdown and June 180 200 nationwide CO2 shortage constrained Today 121 ~180 Aerogel production 20 40 60 80 10
Slide 5: Q3 2022 Financial Highlights
Q3 2022 Financial Highlights Q3 YTD Q3 YTD $ in millions except per share figures Q3 2021 Q3 20221 2022 Outlook1 Commentary 2021 20221 Quarter affected by “slight shift” in EV REVENUES $30.4 $36.7 $90.1 $120.8 $180.0 volume acceleration, scheduled annual YoY Growth 26% 21% 17% 34% 48% Aerogel plant
Slide 6: EV Thermal Barrier Commercial Progress
EV Thermal Barrier Commercial Progress Aspen has been awarded business, is quoting, or in discussions with several OEMs that it believes will drive EV production 2025 Forecasted EV Production Volume (M units) and Sourcing Status by OEM Group HQ Location 1 North America Western Europe Asia TAM 8.7 TA
Slide 7: Our Strategy to Create Stakeholder Value
Our Strategy to Create Stakeholder Value Leveraging our platform in markets with favorable dynamics while focusing on doing the right things well creates value WHO WE ARE WHAT WE DO CREATES VALUE PROPRIETARY AEROGEL TM OPTIMIZE AND EXPAND OUR PLATFORM Peers’ 1 Revenue Growth / EBITDA Margins 2 side
Slide 8: Appendix
Appendix GAAP-Non-GAAP Reconciliation
Slide 9: GAAP to Non-GAAP Reconciliation
GAAP to Non-GAAP Reconciliation Q3 Q3 YTD FY 2022 ($ in thousands) 2022 2021 2022 2021 Low High Net loss (29,595) (7,822) (73,129) (20,741) (86,800) (82,300) Depreciation and Amortization 2,531 2,114 6,692 6,856 9,700 9,700 Stock-based Compensation 2,590 1,554 6,713 3,600 8,300 8,300 Gain on Extingu
Slide 10: - ASPEN|acrogels
- ASPEN|acrogels